Please enable Javascript in your Browser to experience full features of this website.
AIDS
info
Mobile
|
1-800-HIV-0440
|
Live Chat
|
Contact Us
|
En Español
Search Here:
skip navigation
Home
Guidelines
Antiretroviral Treatment
Adult and Adolescent Treatment Guidelines
Pediatric Treatment Guidelines
Maternal-Child Transmission
Perinatal Guidelines
Management of HIV Complications
Prevention and Treatment of Opportunistic Infections Guidelines: Adults and Adolescents
Prevention and Treatment of Opportunistic Infections Guidelines: Children
Incorporation of HIV Prevention
Care for Disaster Displaced HIV-Infected Patients
Guidance for Non-HIV-Specialized Providers
Post-Exposure Prophylaxis
Health-Care Worker Exposure Guidelines
Nonoccupational Exposure Considerations
Testing
Revised Guidelines for Counseling, Testing, and Referral
Search the Guidelines
Please Select a Guideline
Adult and Adolescent Guidelines
Pediatric Guidelines
Perinatal Guidelines
Search Guidelines
Clinical Trials
Clinical Trials Search Options
Search by Keyword
Search by Category
Select a topic
Cancer
Coinfections
Complications/Side Effects
Opportunistic Infections
Prevention Research
Specific Populations
Treatment Research
Vaccine Research
Trials by Age
Trials by Study Type
Search by Topics
Select a subtopic
Advanced Search
Download Education Materials
What is an HIV/AIDS Clinical Trial (PDF)
Preventive HIV Vaccines (PDF)
Therapeutic HIV Vaccines (PDF)
Drugs
FDA-approved
Combination Drugs
Entry and Fusion Inhibitors
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Opportunistic Infection and Other Drugs
Protease Inhibitors
Investigational
Entry and Fusion Inhibitors
Integrase Inhibitors
Microbicides
Nucleoside Reverse Transcriptase Inhibitors
Opportunistic Infection and Other Drugs
Search HIV/AIDS Drugs
Alphabetical Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Drugs
HIV/AIDS Health Topics
HIV/AIDS-Related Guidelines
Staying Healthy with HIV
Specific Populations
Treatment Resources
Coinfections
Prevention Research
General Information
Clinical Research
For Health Care Providers
For Researchers
Search HIV/AIDS Health Topics
Alphabetical Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Topics
Education Materials
Glossary
HIV and Its Treatment Fact Sheet (PDF)
Pregnancy Fact Sheet (PDF)
More Fact Sheets
HIV/AIDS Awareness Day Pages
Homework Help
Search the Glossary
(Other Education Materials not included)
Alphabetical Glossary Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Glossary Terms
Mobile Resources & Tools
Mobile Site
Apps
APIs
Widgets
Order Publications
Site Map
Home
> Site Map
Español
Text Size
Guidelines
Adult and Adolescent Guidelines
Adult and Adolescent Treatment Guideline, Printer Friendly Version (PDF)
Adult and Adolescent Guidelines : Guideline, Web Version (HTML)
Adult and Adolescent Guidelines: Panel Roster (PDF)
Adult and Adolescent Guidelines: Tables (PDF)
Adult and Adolescent Guidelines: Patient Education Materials (HTML)
Pediatric Guidelines
Pediatric Guidelines: Guideline, Printer Friendly Version (PDF)
Pediatric Guidelines: Guideline, Web Version (HTML)
Pediatric Guidelines: Recommendations Only (PDF)
Pediatric Guidelines: Drug Tables (PDF)
Pediatric Guidelines: Financial Disclosure (PDF)
Pediatric Guidelines: Patient Education Materials (HTML)
Perinatal Guidelines
Perinatal Guidelines: Guideline, Printer Friendly Version (PDF)
Perinatal Guidelines: Guideline, Web Version (HTML)
Perinatal Guidelines: Recommendations Only (PDF)
Perinatal Guidelines: Fluconazole FDA Drug Safety (PDF)
Perinatal Guidelines: Tables (PDF)
Perinatal Guidelines: Financial Disclosure (PDF)
Perinatal Guidelines: Patient Education Materials (HTML)
Prevention and Treatment of Opportunistic Infections Guidelines: Adults and Adolescents: Guideline, Printer-Friendly Version (PDF)
Prevention and Treatment of Opportunistic Infections Guidelines: Adults and Adolescents: Panel Roster and Financial Disclosure(PDF)
Prevention and Treatment of Opportunistic Infections Guidelines: Children
Prevention and Treatment of Opportunistic Infections Guidelines: Children: Guideline, Printer-Friendly Version (PDF)
Prevention and Treatment of Opportunistic Infections Guidelines: Children: Important New Pediatric Dosing Information about Valcyte (valganciclovir) (PDF)
Incorporation of HIV Prevention
Incorporation of HIV Prevention: MMWR: Incorporating HIV Prevention into the Medical Care of Persons Living with HIV (HTML)
Guidance for Non-HIV-Specialized Providers
Guidance for Non-HIV-Specialized Providers: Care for Disaster Displaced HIV-Infected Patients (PDF)
Health-Care Worker Exposure Guidelines: MMWR: Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis (PDF)
Health-Care Worker Exposure Guidelines: Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis (HTML)
Nonoccupational Exposure Considerations: MMWR: Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States (PDF)
Nonoccupational Exposure Considerations: Management of Possible Sexual, Injection-Drug-Use, or Other Nonoccupational Exposure to HIV, Including Considerations Related to Antiretroviral Therapy (HTML)
Testing: MMWR: Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings (HTML)
Clinical Trials
Search for Open Clinical Trials
Clinical Trial News
Drugs
Search the Drug Database
FDA-Approved Combination Drugs
FDA-Approved Entry and Fusion Inhibitors
FDA-Approved Integrase Inhibitors
FDA-Approved Non-nucleoside Reverse Transcriptase Inhibitors
FDA-Approved Nucleoside Reverse Transcriptase Inhibitors
FDA-Approved Opportunistic Infection and Other Drugs
FDA-Approved Protease Inhibitors
Investigational Entry and Fusion Inhibitors
Investigational Integrase Inhibitors
Investigational Microbicides
Investigational Nucleoside Reverse Transciptase Inhibitors
Investigational Opportunistic Infection and Other Drugs
Drug News
Health Topics
Clinical Research
Clinical Research: Clinical Trials Information
Clinical Research: Grants
Coinfections
Coinfections: Hepatitis
Coinfections: Opportunistic Infections
Coinfections: Other Infections
Coinfections: Tuberculosis
For Health Care Providers
For Health Care Providers: Cultural Competency
For Health Care Providers: Hotlines
For Health Care Providers: Skills Training
For Researchers
For Researchers: Grants
For Researchers: Other Resources for Researchers
For Researchers: Resources for Laboratory Researchers
Staying Healthy with HIV
Staying Healthy with HIV: Immunizations
Staying Healthy with HIV: Influenza
Staying Healthy with HIV: Information for Travelers
Staying Healthy with HIV: Mental Health
Staying Healthy with HIV: Newly Diagnosed
Staying Healthy with HIV: Nutrition/Food Safety
Staying Healthy with HIV: Oral Health
General Information
General Information: Basic HIV/AIDS Information
General Information: General HIV Prevention Information
General Information: History of HIV
General Information: HIV Life Cycle
General Information: HIV Policies and Programs
General Information: HIV/AIDS Images
General Information:Printed Reference Material
General Information:Statistics
Prevention Research
Prevention Research: Microbicides
Prevention Research: Mother-to-Child Transmission of HIV
Prevention Research: Post-Exposure Prophylaxis
Prevention Research: Pre-Exposure Prophylaxis
Prevention Research: Preventive HIV Vaccine
Education Materials
HIV/AIDS Fact Sheets
AIDS
info
Glossary of HIV/AIDS-Related Terms
HIV/AIDS Awareness Day Pages
Homework Help
Glossary
AIDS
info
English Glossary
AIDS
info
Spanish Glossary
Mobile Resources and Tools
Explore Mobile Resources
View AIDS
info
Mobile Site
AIDS
info
Applications
APIs
Widgets
HIV/AIDS News
AIDS
info
E-News
Guidelines
Clinical Trials
Drugs
Other
About Us
Contact Us
Live Help
Mobile Resources
Privacy Policy
FOIA
Accessibility
Sponsors